Facebook
Instagram
Pinterest
Reddit
Tumblr
X
Youtube
Home
About
News
Events
Shop
Directory
Contact Us
Search
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Password recovery
Recover your password
your email
A password will be e-mailed to you.
PsyNews.com
Home
About
News
Events
Shop
Directory
Contact Us
Home
Featured
Page 320
Featured
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
The Problems We Will Be Lucky to Have
Pα+ Psychedelic Bulletin #234: Psychedelics After the Midterms; FDA Answers House Psychedelics Caucus; ICER to Review Compass’ Psilocybin; Terran v. Compass Gets Trial Date
Is It Worth It? What Colorado’s Early Experience With Regulated Psychedelic Care Has the Field Asking, and What To Do About It
Compass Says NDA Will Be Filed Within Two Weeks, Declines to Comment on Usona
Podcast: Usona Files Psilocybin Application, We Review 610 Comments Submitted to FDA, and FDA Approves NRx’s Generic Ketamine
PTSF 46 – Patents, Prohibition, Health, and Happiness
New Age Animism: A Consciousness Theory With a Psychedelic Twist
Progressive Doctor Thinks Psychedelics May Be Used to Revive Comatose Patients
MINDCURE Announces Listing of Warrants
PharmaDrug Files for FDA Orphan Drug Designation for DMT in Stroke
Nova Mentis Appoints Gary R. Harlem to Scientific Advisory Board
MindMed Signs Partnership with Swiss Psychedelic Drug Discovery Startup MindShift Compounds...
MindMed Signs Partnership with Swiss Psychedelic Drug Discovery Startup MindShift Compounds...
Tryp Therapeutics Appoints Dr. Joel Castellanos as Clinical Advisor
Study: 69% of Suicidal Patients Saw ‘Significant’ Improvement With Ketamine Therapy
Load more